In addition to its role in tumorigenesis, however, MGMT plays a critical role in the cellular response to alkylating agents; its epigenetic silencing via methylation is a strong predictive biomarker for response to alkylating agents in glioblastoma, colorectal cancer, and Hodgkin lymphoma56–58. Here, MGMT is linked to glioblastoma.